Informazione:
Errore:
ID
34602
Descrizione
Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION); ODM derived from: https://clinicaltrials.gov/show/NCT01541956
collegamento
https://clinicaltrials.gov/show/NCT01541956
Keywords
versioni (1)
- 19/01/19 19/01/19 -
Titolare del copyright
see on clinicaltrials.gov
Caricato su
19 gennaio 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Type 2 Diabetes NCT01541956
Eligibility Type 2 Diabetes NCT01541956
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT01541956
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
ID.1
Item
chinese t2d patients who are inadequate controlled (6.5 %< hba1c ≤9%) by metformin (≥750mg/d but ≤1000mg/d, ≥12 weeks),
boolean
ID.2
Item
type 1 diabetes and secondary diabetes
boolean
ID.3
Item
acute metabolic diabetic complications within the past 3 months.
boolean
ID.4
Item
acute infections which may influence glucose level.
boolean
ID.5
Item
evidence of significant chronic diabetic complications,
boolean
ID.6
Item
clinically significant renal impairment and hepatic impairment patients, including history of cirrhosis or chronic hepatitis,
boolean
ID.7
Item
fpg > 270 mg/dl (15 mmol/l)
boolean
ID.8
Item
any of the following disease within the past 6 months: myocardial infarction (mi); coronary artery bypass surgery or percutaneous coronary intervention; unstable angina or stroke; congestive heart failure (chf)
boolean
ID.9
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean